Norris Perne & French LLP Nuvasive Inc Transaction History

Norris Perne & French LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 28, 2019	SELL	$47.64 - $71.26 $7.7 Million - $11.5 Million	-161,612 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$52.03 - $71.41 $592,257 - $812,860	-11,383 Reduced 6.58%	161,612 $11.5 Million
Q2 2018 Jul 24, 2018	SELL	$48.15 - $56.68 $102,511 - $120,671	-2,129 Reduced 1.22%	172,995 $9.02 Million
Q1 2018 Apr 17, 2018	BUY	$46.03 - $61.28 $788,770 - $1.05 Million	17,136 Added 10.85%	175,124 $9.14 Million
Q4 2017 Jan 23, 2018	SELL	$50.58 - $60.79 $365,743 - $439,572	-7,231 Reduced 4.38%	157,988 $9.24 Million
Q3 2017 Nov 01, 2017	BUY	$53.54 - $68.0 $8.85 Million - $11.2 Million	165,219	165,219 $9.16 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

Stay updated on Norris Perne & French LLP with notifications on news.